An Exeter Hospital hand surgeon's work is connecting carpal tunnel syndrome to a rare, life-threatening heart condition— and ...
Art Still has ATTR amyloidosis, an inherited heart condition that dramatically impacts Black men and the former Kansas City Chiefs defensive end wants to raise awareness.
US Transthyretin Amyloidosis Treatment Market Growth BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The U.S. transthyretin a ...
AstraZeneca (AZ) and Ionis Pharmaceuticals’ Wainzua (eplontersen) has been approved by the European Commission (EC) to treat ...
Erythropoietin-producing hepatoma (Eph) receptors, including EphA4, are expressed on the cell surface and involved in brain development, which involves extensive pruning of synapses. A variant in ...
Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in ...
The leading AL Amyloidosis Companies such as Caelum Biosciences, Nexcella, Inc., HaemaLogiX Ltd., Prothena, ZENTALIS PHARMACEUTICALS, Sorrento Therapeutics, Inc., and others.
ALNY stock soars 62% in a year, driven by increasing Amvuttra and Givlaari sales. Its ongoing collaboration deals with RHHBY, NVS and REGN are progressing well.
In this deep dive, BioSpace explores the diverse therapeutic modalities now in development, as well as the opportunities and ...
“Today’s approval of WAINZUA in Europe offers adults with hereditary transthyretin-mediated amyloidosis with polyneuropathy a new, self-administered treatment option that provides consistent ...
Ionis Pharmaceuticals (IONS) announced that Ionis and AstraZeneca’s (AZN) WAINZUA eplontersen has been approved in the European Union EU for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results